摘要:Kaleo公司宣布美国FDA批准肾上腺素(Auvi—Q)0.1mg自动注射针治疗婴幼儿(体质量7.5~15kg)危重过敏反应。FDA优先审评此药的补充新药申请后,认为自动注射针较短、药物剂量较小,其安全性和有效性改善,同意批准。过敏反应由于发生迅速,可引起死亡,通常由暴露于过敏原而引发,包括坚果、花生、牛奶、蛋、鱼、贝类、大豆、小麦、虫咬、乳胶和药物。治疗前应先脱离过敏原,然后再用此针剂治疗。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering